| 英文别名： |
dinoprost;prostaglandin F2-alpha;Prostaglandin F2A;9,11,15-trihydroxyprosta-5,13-dien-1-oicacid;amoglandin;cyclosin;dinolytic;enzaprost;enzaprostf;glandin;Prostaglandin F2alpha;tromethamine;Prostaglandin F2α;Prostaglandin F2α Lipid Maps MS Standard;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid;[3H]-PGF2alpha;Dinprost;Glandin N;panacelan;PGF2ALPHA;PGF2α;(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxyprosta-5,13-diene-1-oic acid;Cerviprost;Enzaprost F;Protamodin;l-PGF2-alpha;l-Prostaglandin F2-alpha;Dinoprostum;Dinoprosta;Prostin F2alpha;Prostin F2-alpha;PGF2-alpha;PGF2 alpha;PGF-2alpha;Prostarmon F;Prostaglandin F2 alpha;9alpha,11alpha-PGF2;PGF2;Prostaglandin F(sub 2a);Dinoprostum [INN-Latin];Dinoprosta [INN-Spanish];U 14583;Prostaglandin F2;Din;Dinoprost;Prostaglandin F2-alpha;DINOPROST [HSDB];9a,11a-PGF2;(+)-Prostaglandin F2a;HMS1361K16;NCGC00160385-04;Prostaglandin F2.alpha.;PDSP2_000079;Tox21_111777;SCHEMBL24292;B7IN85G1HY;7-(3, 5-dihydroxy-2-(3-hydroxyl-1-octenyl) cyclopentyl)-5-heptenoic acid;NCGC00160385-05;BML1-F08;(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid;Prostaglandin F2a;U-14583;(5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid;1ST11386;BDBM50035622;BRN 4153898;DB12789;A830494;CHEMBL815;Dinoprost [USAN:INN:BAN:JAN];Prostaglandin F2-alpha, racemic mixt.;PGF2alpha;Prostin F 2 alpha;5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, l-;prostaglandin F2alpha;5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(S*,E),3alpha,5alpha))-;Dinaprost;15(R)-Prostaglandin F2 alpha;LMFA03010002;NCGC00160385-06;5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-1-OCTENYL)CYCLOPENTYL)-, dl-;(5z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprosta-5,13-dienoic acid;(E,Z)-(1R,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid;9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid;Dinoprostum (INN-Latin);Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-;Enzaprost;F2alpha, Prostaglandin;Prosmon (TN);PGF2.alpha.;(5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid;dl-Prostaglandin F2-alpha;15-epi PGF2alpha;(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-cyclopentyl)-hept-5-enoic acid;Prostaglandin-F2alpha;(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-3,13-dien-1-oic acid;U-14,583;HMS2089F11;CCG-208257;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;G02AD01;7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid;NCGC00160385-01;F2 alpha, Prostaglandin;Prostaglandin F2alpha, dl-;BSPBio_001494;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid;GTPL1884;P1885;HY-1295... |
沪公网安备 
